References
- Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M,
Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB.
Reduced mortality after allogeneic hematopoietic-cell transplantation.
N Engl J Med. 2010 Nov 25;363(22):2091-2101.
- Svenberg P, Remberger M, Uzunel M, Mattsson J, Gustafsson B, Fjaertoft
G, Sundin M, Winiarski J, Ringdén O. Improved overall survival for
pediatric patients undergoing allogeneic hematopoietic stem cell
transplantation - A comparison of the last two decades. Pediatr
Transplant. 2016 Aug;20(5):667-674.
- Paix A, Antoni D, Waissi W, Ledoux MP, Bilger K, Fornecker L, Noel G.
Total body irradiation in allogeneic bone marrow transplantation
conditioning regimens: A review. Crit Rev Oncol Hematol. 2018
Mar;123:138-148.
- McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn
TF, Schoch HG, Anasetti C, Gooley T. Cyclophosphamide metabolism,
liver toxicity, and mortality following hematopoietic stem cell
transplantation. Blood. 2003 Mar 1;101(5):2043-2048.
- Ishida H, Adachi S, Hasegawa D, Okamoto Y, Goto H, Inagaki J, Inoue M,
Koh K, Yabe H, Kawa K, Kato K, Atsuta Y, Kudo K. Comparison of a
fludarabine and melphalan combination-based reduced toxicity
conditioning with myeloablative conditioning by radiation and/or
busulfan in acute myeloid leukemia in Japanese children and
adolescents. Pediatr Blood Cancer. 2015 May;62(5):883-889.
- Harada K, Tachibana T, Ohashi K, Ozawa Y, Sawa M, Kondo T, Ishikawa J,
Onizuka M, Imada K, Fujisaki T, Tanaka J, Fukuda T, Atsuta Y, Kako S.
The effect of melphalan dose and total body irradiation as
reduced-intensity conditioning for acute lymphoblastic leukemia
patients undergoing allogeneic stem cell transplantation. Leuk
Lymphoma. 2019 Dec;60(14):3521-3528.
- Bitan M, He W, Zhang MJ, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter
PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR,
Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA,
Prestidge T, Seber A, Shenoy S, Woolfrey AE, Yu LC, Davies SM.
Transplantation for children with acute myeloid leukemia: a comparison
of outcomes with reduced intensity and myeloablative regimens. Blood.
2014 Mar 6;123(10):1615-1620.
- Satwani P, Cooper N, Rao K, Veys P, Amrolia P. Reduced intensity
conditioning and allogeneic stem cell transplantation in childhood
malignant and nonmalignant diseases. Bone Marrow Transplant. 2008
Jan;41(2):173-182.
- Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M,
Hosing C, Anderlini P, Donato M, Cleary K, Gajewski J, Neumann J,
Ippoliti C, Rondon G, Cohen A, Champlin R. Acute and chronic
graft-versus-host disease after ablative and nonmyeloablative
conditioning for allogeneic hematopoietic transplantation. Biol Blood
Marrow Transplant. 2004 Mar;10(3):178-185.
- Pérez-Simón JA, Díez-Campelo M, Martino R, Brunet S, Urbano A,
Caballero MD, de León A, Valcárcel D, Carreras E, del Cañizo MC,
López-Fidalgo J, Sierra J, San Miguel JF. Influence of the intensity
of the conditioning regimen on the characteristics of acute and
chronic graft-versus-host disease after allogeneic transplantation. Br
J Haematol. 2005 Aug;130(3):394-403.
- Oran B, Wagner JE, DeFor TE, Weisdorf DJ, Brunstein CG. Effect of
conditioning regimen intensity on acute myeloid leukemia outcomes
after umbilical cord blood transplantation. Biol Blood Marrow
Transplant. 2011 Sep;17(9):1327-1334.
- Salas MQ, Chen S, Lam W, Pasic I, Gerbitz A, Michelis FV, Kim DDH,
Al-Shaibani Z, Lipton JH, Mattsson J, Kumar R, Viswabandya A, Law AD.
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free
Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion
in Acute Myelogenous Leukemia. Biol Blood Marrow Transplant. 2020
Aug;26(8):1511-1519.
- Terwey TH, Vega-Ruiz A, Hemmati PG, Martus P, Dietz E, le Coutre P,
Massenkeil G, Dörken B, Arnold R. NIH-defined graft-versus-host
disease after reduced intensity or myeloablative conditioning in
patients with acute myeloid leukemia. Leukemia. 2012
Mar;26(3):536-542.
- Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J,
Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone
Marrow Transplant. 1995 Jun;15(6):825-828.
- Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ,
Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P,
Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G,
Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H,
Turner M, Vogelsang G, Flowers ME. National Institutes of Health
consensus development project on criteria for clinical trials in
chronic graft-versus-host disease: I. Diagnosis and staging working
group report. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-956.
- Kanda Y. Investigation of the freely available easy-to-use software
’EZR’ for medical statistics. Bone Marrow Transplant. 2013
Mar;48(3):452-458.
- Peters LJ, Withers HR, Cundiff JH, Dicke KA. Radiobiological
considerations in the use of total-body irradiation for bone-marrow
transplantation. Radiology. 1979 Apr;131(1):243-247.
- Wheldon TE. The radiobiological basis of total body irradiation. Br J
Radiol. 1997 Dec;70(840):1204-1207.
- Uckun FM, Jaszcz W, Chandan-Langlie M, Waddick KG, Gajl-Peczalska K,
Song CW. Intrinsic radiation resistance of primary clonogenic blasts
from children with newly diagnosed B-cell precursor acute
lymphoblastic leukemia. J Clin Invest. 1993 Mar;91(3):1044-1051.
- Dutreix J, Wambersie A, Loirette M, Boisserie G. Time factors in total
body irradiation. Pathol Biol (Paris). 1979 Jun;27(6):365-9.
- Uckun FM, Chandan-Langlie M, Jaszcz W, Obuz V, Waddick K, Song CW.
Radiation damage repair capacity of primary clonogenic blasts in acute
lymphoblastic leukemia. Cancer Res. 1993 Mar 15;53(6):1431-1436.
- Pearson AE, Steel GG. Chemotherapy in combination with pelvic
irradiation: a time-dependence study in mice. Radiother Oncol. 1984
Jun;2(1):49-55.
- Collis CH, Steel GG. Lung damage in mice from cyclophosphamide and
thoracic irradiation: the effect of timing. Int J Radiat Oncol Biol
Phys. 1983 May;9(5):685-9.
- Parkins CS, Whitsed CA, Fowler JF. Repair kinetics in mouse lung after
multiple X-ray fractions per day. Int J Radiat Biol. 1988
Sep;54(3):429-443.
- Van Rongen E, Kuijpers WC, Madhuizen HT. Fractionation effects and
repair kinetics in rat kidney. Int J Radiat Oncol Biol Phys. 1990
May;18(5):1093-1106.
- Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Petersen FB, Fisher
LD, Anasetti C, Beatty P, Bensinger WI, Doney K, et al. Allogeneic
marrow transplantation in patients with acute myeloid leukemia in
first remission: a randomized trial of two irradiation regimens.
Blood. 1990 Nov 1;76(9):1867-1871.
- Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura
K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T,
Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the
Japan Society of Hematopoietic Cell Transplantation. Impact of
conditioning intensity and TBI on acute GVHD after hematopoietic cell
transplantation. Bone Marrow Transplant. 2015 Apr;50(4):559-565.
- Harris AC, Ferrara JL, Levine JE. Advances in predicting acute GVHD.
Br J Haematol. 2013 Feb;160(3):288-302.
- Baron F, Baker JE, Storb R, Gooley TA, Sandmaier BM, Maris MB, Maloney
DG, Heimfeld S, Oparin D, Zellmer E, Radich JP, Grumet FC, Blume KG,
Chauncey TR, Little MT. Kinetics of engraftment in patients with
hematologic malignancies given allogeneic hematopoietic cell
transplantation after nonmyeloablative conditioning. Blood. 2004 Oct
15;104(8):2254-2262.
- Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S. Reduced-intensity
allogeneic hematopoietic stem cell transplantation for acute
leukemias: ’what is the best recipe?’. Bone Marrow Transplant. 2005
Oct;36(7):565-574.
- Pérez-Simón JA, Caballero D, Diez-Campelo M, Lopez-Pérez R, Mateos G,
Cañizo C, Vazquez L, Vidriales B, Mateos MV, Gonzalez M, San Miguel
JF. Chimerism and minimal residual disease monitoring after reduced
intensity conditioning (RIC) allogeneic transplantation. Leukemia.
2002 Aug;16(8):1423-1431.
- Elkaim E, Picard C, Galambrun C, Barlogis V, Loundou A, Curtillet C,
Oudin C, Thuret I, Chambost H, Michel G. Peripheral blood cells
chimerism after unrelated cord blood transplantation in children:
kinetics, predictive factors and impact on post-transplant outcome. Br
J Haematol. 2014 Aug;166(4):557-565.
- Balon J, Hałaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L,
Piekarska A, Pawłowski R, Hellmann A. Early complete donor
hematopoietic chimerism in peripheral blood indicates the risk of
extensive graft-versus-host disease. Bone Marrow Transplant. 2005
Jun;35(11):1083-1088.
- Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R,
Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I,
López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund
H. Reduced intensity conditioning increases risk of severe cGVHD:
identification of risk factors for cGVHD in a multicenter setting. Med
Oncol. 2018 Apr 25;35(6):79.
- Perruche S, Marandin A, Kleinclauss F, Angonin R, Fresnay S, Baron MH,
Tiberghien P, Saas P. Association of mixed hematopoietic chimerism
with elevated circulating autoantibodies and chronic graft-versus-host
disease occurrence. Transplantation. 2006 Feb 27;81(4):573-582.